Deliver Your News to the World

The Bedford Report Issues Free Research Reports On AEGR, CYTR, BWEN and MNKD


JERICHO, NY, October 22, 2012, The Bedford Report has released new equity reports today. As a leading provider of free in-depth reports and timely market updates, Bedford has been an essential resource for hundreds of thousands of investors across the country.

Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) shares surged nearly 10 percent last week after it was reported the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommended approval of lomitapid for the treatment of Homozygous Familial Hypercholesterolemia.

Find out more about Aegerion Pharmaceuticals including full access to the free equity report at:

Broadwind Energy Inc. (NASDAQ: BWEN) shares soared as much as 30 percent last Thursday on large volume. The company has reported it has been awarded $37 million in tower orders, which they will begin manufacturing in late 2012.

Find out more about Broadwind including full access to the free equity report at:

CytRx Corporation (NASDAQ: CYTR) declined nearly 20 percent last Thursday after announcing the pricing of a public offering of 8 million shares of common stock. The company recently initiated a single-center Phase 1b clinical trial for aldoxorubicin in the treatment of metastatic solid tumors.

Find out more about CytRx including full access to the free equity report at:

MannKind Corporation (NASDAQ: MNKD) shares declined over 20 percent on over 27 million shares traded. The company announced the pricing last Thursday of underwritten public offering of 40 million shares of its common stock. Each share will be sold with a warrant for a combined purchase price of $2.00.

Find out more about MannKind including full access to the free equity report at:

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid SmallCapNewsRelease one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. In light of the above, we accept no liability for any losses arising from an investor’s reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

(516) 942-4910


 Research Reports

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.